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Abstract.
Background: Changes in episodic memory are common early in Parkinson’s disease (PD) and may be a risk factor for future
cognitive decline. Although medial temporal lobe (MTL) memory and frontostriatal (FS) executive systems are thought to play
different roles in distinct components of episodic memory impairment in PD, no study has investigated whether different aspects
of memory functioning are differentially associated with MTL and FS volumes in nondemented patients without mild cognitive
impairment (PD-woMCI).
Objectives: The present study investigated MRI markers of different facets of memory functioning in 48 PD-woMCI patients
and 42 controls.
Methods: Regional volumes were measured in structures comprising the MTL and FS systems and then correlated with key
indices of memory from the California Verbal Learning Test.
Results: In PD-woMCI patients, memory was impaired only for verbal learning, which was not associated with executive,
attention/working memory, or visuospatial functioning. Despite an absence of cortical atrophy, smaller right MTL volumes in
patients were associated with poorer verbal learning, long delayed free recall, long delayed cued recall, and recognition memory
hits and false positives. Smaller right pars triangularis (inferior frontal) volumes were also associated with poorer long delayed
cued recall and recognition memory hits. These relationships were not found in controls.
Conclusions: The findings indicate that MTL volumes are sensitive to subtle changes in almost all facets of memory in
PD-woMCI, whereas FS volumes are sensitive only to memory performances in cued-testing formats.
Keywords: Parkinson’s disease, magnetic resonance imaging, memory, neuropsychology, medial temporal lobe system, fron-
tostriatal system, cognitive functions
INTRODUCTION
Cognitive impairments are found early in the course
of Parkinson’s disease (PD), and up to 80% of patients
show dementia 8-years later [1]. Dementia lowers the
quality of life for patients and caregivers alike, and
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dharrington@ucsd.edu.
portends a greater risk of nursing home placement and
mortality [2, 3]. Markers of cognitive functioning in
PD are needed that predate the onset of mild cogni-
tive impairment (MCI). Once markers are identified,
they can then be studied longitudinally to chart the rate
of disease progression and determine which markers
predict risk for dementia.
Episodic memory impairment is common early in
PD and may be a risk factor for future cognitive decline
[4, 5]. However, neuroanatomical substrates of subtle
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changes in memory that predate cognitive impairment
have not been comprehensively studied in nonde-
mented PD patients without mild cognitive impairment
(PD-woMCI) using recent criteria [6]. Most investiga-
tions have almost solely focused on the relationship of
memory to hippocampus and entorhinal cortex mor-
phometry, owing to their roles in memory encoding and
consolidation. Cross-sectional studies of combined
samples of PD patients with and without cognitive
impairment typically report that medial temporal lobe
(MTL) volumes correlate with various aspects of ver-
bal memory including delayed recall and recognition
memory [7–13]. However, frontostriatal (FS) networks
also mediate executive aspects of episodic memory,
which govern attention and working memory and self-
initiated search and monitoring strategies at encoding
and retrieval [14, 15]. Recently, our group found that
poorer long delayed free recall in nondemented PD
was associated with reduced MTL and FS volumes in
both hemispheres, suggesting that memory and execu-
tive systems are associated with early, subtle memory
changes [16]. This study may have included some
patients with MCI, thereby preventing an examination
of the systems associated with memory functioning
before mild cognitive impairment [6].
In clinical evaluations of PD, different components
of verbal memory are typically examined including
learning, retention, retrieval, and the types of errors
during recall. It is traditionally believed that impaired
learning in nondemented PD is largely due to ineffi-
cient use of strategies during encoding because of FS
dysfunction [17]. For example, one study reported that
poorer verbal learning in PD patients with and with-
out MCI was not related to hippocampal atrophy [7],
speculating that verbal encoding deficits, secondary to
inefficient use of learning strategies, may be related
to changes in the FS system, which was not exam-
ined. To our knowledge, no study has directly tested
this hypothesis by correlating multiple facets of verbal
learning and memory with FS volumes.
Another important distinction is whether a patient
has retention or retrieval difficulties. It is widely
believed that PD patients exhibit retrieval deficits.
Indeed, nondemented PD patients demonstrate
impaired free recall, yet memory performance can
improve to normal or near normal levels when cues or
yes/no recognition testing formats are used [18–20],
which decrease retrieval demands. This memory
profile is attributed to deficient retrieval rather than
retention of stored information, ostensibly due to FS
dysfunction, which disrupts strategies for search and
retrieval of information [18]. In contrast, patients with
MTL damage (e.g., Alzheimer’s disease) show rapid
rates of forgetting and fail to benefit from cueing and
recognition testing, owing to impaired consolidation
secondary to hippocampal atrophy [18, 21].
However, nondemented PD patients can present
with different patterns of memory impairment [22–26].
Our group found retrieval deficits (i.e., significantly
better recognition memory than free recall) in about
1/3 of PD patients [23]. The remaining patients did
not benefit from recognition memory testing due to
increased endorsement of non-list items as targets
(false positives), presumably related to impaired inhi-
bition secondary to FS dysfunction. It is also possible
that lack of benefit from recognition memory testing
in PD was related to impaired encoding/consolidation
due to hippocampal dysfunction. This demonstrates
the importance of assessing multiple components of
memory. Moreover, while assumptions are frequently
made in clinical practice about the different roles
of FS and MTL systems in distinct components of
episodic memory impairment, no study has investi-
gated whether various aspects of memory functioning
are differentially associated with MTL and FS vol-
umes in PD-woMCI. This is an important question
because neuroanatomical correlates of different facets
of memory may suggest MRI markers of future mem-
ory decline, which could then be studied longitudinally
to determine if they are risk factors for dementia.
The current study sought to elucidate MRI mark-
ers of subtle changes in different aspects of episodic
verbal memory in PD-woMCI, which was evaluated
by a widely used test (California Verbal Learning Test
II– Short Form) [27]. We focused on measures that
are routinely used in clinical assessments of PD [27]
and are theoretically relevant, namely indices of learn-
ing, long delay free recall, retention, cued retrieval
(cued recall relative to free recall), and recognition
retrieval (recognition memory relative to free recall).
These measures were correlated with regional volumes
comprising the MTL memory and the FS executive
systems. We hypothesized that poorer verbal learning
would most strongly correlate with FS volumes, sec-
ondary to difficulties in executive aspects of encoding.
We also hypothesized that the relative improvement
in delayed recall with cued recall and recogni-
tion memory formats (cued retrieval and recognition
retrieval indices) would best correlate with FS vol-
umes, since these indices emphasize executive aspects
of retrieval. In contrast, long delay free recall and reten-
tion were predicted to correlate most strongly with
MTL volumes, owing to their emphasis on memory
consolidation.
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METHOD
Participants
The University of California San Diego Human
Research Protections Program approved this study.
Study participants included 48 PD-woMCI (see defini-
tion for MCI below) and 42 healthy controls (HC) who
were spouses of patients or community volunteers. Par-
ticipants provided written informed consent prior to
study procedures. Thirty-eight of the HC participants
and 43 of the PD participants partially overlapped with
the cohort from our prior study that investigated asso-
ciations between individual differences in volumes of
four brain systems and performances in five cognitive
domains [16]. Exclusion criteria included metal in the
head, neurological diagnoses other than PD, psychi-
atric diagnoses, MCI, history of alcohol or substance
abuse, positive MRI findings (e.g., infarcts, clinically
significant vascular disease), and use of anticholin-
ergics or cognitive medications (e.g., donepezil). PD
participants met the PD United Kingdom Brain Bank
Criteria. All PD patients were taking levodopa or lev-
odopa combination therapy and were tested while on
medication. The groups did not differ in gender compo-
sition, years of education, age, or Mini-Mental Status
Exam (MMSE) scores (Table 1). Motor symptoms
were assessed using Part III of the Unified Parkin-
son’s Disease Rating Scale (UPDRS) and the Hoehn
and Yahr scale. Motor symptom severity and disease
duration (Table 1) were similar to other PD-woMCI
samples [28–31].
PD-woMCI criteria
PD participants were excluded if they met criteria
for PD-MCI based on a modified (no language test)
Level 1 Movement Disorders Society task force criteria
[6], which was assessed using four cognitive domains:
1) Executive function: Letter Fluency (number cor-
rect) from the Delis Kaplan Executive Function System
(DKEFS), 2) Verbal memory: CLVT long delayed free
recall (total correct), 3) Attention/working memory:
Digit Span Backward (Wechsler Adult Intelligence
Scale – III; total correct), and 4) Visuospatial func-
tion: Benton Judgment of Line Orientation test (JLOT;
version V, number correct out of 15 items). Although
we did not have a measure of language, as recom-
mended for a Level 1 PD-MCI diagnosis, language
skills are typically spared in patients without deficits in
other cognitive domains [28]. Owing to the high educa-
tional level of our sample, raw scores for the cognitive
tests were transformed to z-scores based on the HC
group mean and standard deviation [6]. PD-MCI was
diagnosed if a patient demonstrated a z-score ≤–1.5
on at least 2 neuropsychological measures. Of 56
patients in the original sample, 48 met criteria for PD-
woMCI. There were no significant differences between
PD-woMCI and HC groups in executive functioning,
attention/working memory, visuospatial function, or
verbal memory (long delay free recall) (Tables 1 and 2).
Memory assessment
The California Verbal Learning Test – Second Edi-
tion Short Form (CVLT) [27] was used to assess
memory. CVLT variables were first normalized to the
HC group by calculating z-scores based on the HC
group mean/standard deviation. We then calculated the
following CVLT indices using the z-scores: 1) learn-
ing [number of words recalled on learning trials 1–4],
2) long delay free recall [number of words recalled
on the long delay free recall trial], 3) retention [num-
ber of words recalled on trial 4 – number of words on
long delay free recall], 4) cued retrieval [cued recall d
prime (i.e., a discriminability index) [27] – long delay
free recall] and 5) recognition retrieval [recognition
d prime – long delay free recall] [23, 32]. Analyses
were also conducted for sub-measures of the retrieval
indices. Sub-measures comprising the cued retrieval
index included long delay cued recall [number of tar-
get words recalled] and cued recall intrusions [number
of non-list words recalled]. Sub-measures comprising
the recognition retrieval index included recognition
memory hits [number of target words recognized] and
false positives [number of non-list items endorsed].
Higher values on learning, long delayed free recall,
long delay cued recall, and hits indicate better per-
formance. Higher values on retention, cued retrieval,
recognition retrieval, false positives, and cued recall
intrusions indicate worse performance.
MRI procedures
High resolution T1-weighted anatomic images were
acquired on a GE 3T Excite MRI system. Auto-
mated reconstruction and volumetric segmentation
of images were conducted using FreeSurfer 5.1
(http://surfer.nmr.mgh.harvard.edu/), which is widely
used and provides accurate renderings of regional
volumes without rater bias. We used an imaging pro-
tocol that maximizes differentiation of the white and
gray matter boundary (3D spoiled gradient-recalled
at steady state, TE 3.0 ms, TR 7.8 ms, TI 600, 8◦
flip angle, NEX 1, 1-mm axial slice thickness, FOV
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Table 1
Demographics, disease characteristics, and neuropsychological test performances of participants
Parkinson’s (n = 48) Controls (n = 42) F p
Demographics
Age (years) 66.9 (7.9) 66.7 (8.3) 2.5 0.12
Education (years) 17.2 (3.0) 17.1 (2.8) 0.04 0.85
Gender (M/F)a 25/23 21/21 0.39 0.84
Mini-Mental Status Exam 29.0 (1.4) 29.1 (0.9) 2.3 0.14
Disease Characteristics
Duration of PD (years) 6.2 (4.6)
UPDRS III 27.8 (10.0)
Hoehn & Yahr stage
Stage 1/2/2.5/3 (frequency) 3/15/17/13
Levodopa dosage equivalence 678.7 (570.0)
Neuropsychological Tests
Executive: Letter Fluency 44.5 (10.6) 48.1 (11.5) 2.4 0.13
Attention/Working Memory: 7.4 (1.8) 7.8 (2.3) 0.63 0.43
Digit Span Backward
Visuospatial: JLOT 12.0 (2.1) 12.7 (1.9) 2.3 0.13
Brain Volumesb
R Pars triangularis 0.27 (0.05) 0.27 (0.05) 0.03 0.86
R Entorhinal 0.12 (0.03) 0.13 (0.02) 1.2 0.28
R Parahippocampus 0.14 (0.02) 0.14 (0.02) 1.2 0.44
R Hippocampus 0.25 (0.03) 0.26 (0.03) 0.60 0.28
L Temporal Pole 0.16 (0.03) 0.16 (0.03) 0.38 0.54
Demographics, disease characteristics, and neuropsychological test performances are presented as the mean (standard deviation) of raw scores.
Brain volumes for regions that significantly correlated with memory variables in the Parkinson’s group are presented. Frequency counts are
presented for gender and the Hoehn and Yahr stages. aChi-square test for group differences. Test statistic in the F column is a chi-square value.
bBrain volumes (mm3/ICV mm3) for regions that were significantly correlated with various CVLT measures. UPDRS = Unified Parkinson’s
Disease Rating Scale; JLOT = Judgment of Line Orientation; R = right hemisphere; L = left hemisphere.
Table 2
Performances on the verbal memory measure (CVLT)
Parkinson’s Controls
CVLT Variables Mean (SD) Min, Max Mean (SD) Min, Max F p
Learning 27.5 (3.5) 19,35 29.4 (3.1) 23,35 7.4 0.008
Long Delay Free Recall 7.0 (1.8) 3,9 7.5 (1.4) 4,9 2.4 0.13
Retention 0.8 (1.4) –2.0,4.0 0.6 (1.2) –2.0,3.0 0.16 0.69
Cued Retrievala 14 (0.8) –2.2,1.6 0.0 (0.6) –1.3,1.5 0.88 0.35
Long Delay Cued Recall 7.4 (1.5) 3,9 7.8 (1.1) 5,9 2.3 0.13
Cued Recall Intrusionsb 0.3 (0.6) 0,2 0.3 (0.7) 0,3 0.95
Recognition Retrievala 0.1 (1.1) –2.9,2.3 0.0 (0.9) –2.2,2.7 0.14 0.71
Hitsb 8.6 (0.6) 7,9 8.6 (0.7) 6,9 0.76
False Positivesb 1.4 (1.7) 0,6 0.9 (1.1) 0,5 0.15
Note: Memory measures are from the California Verbal Learning Test – Short form (CVLT). aCVLT scores are raw scores, except for cued
retrieval and recognition retrieval, which are z-scores, since they involved subtraction of measures using different metrics. bGroup comparisons
used the Mann-Whitney U test due to the skewed distributions of these variables.
25.6 cm, 256 × 256 matrix). MRIs for each partici-
pant were motion corrected, normalized for intensity
in homogeneities, and transformed to Talairach
space. Non-brain tissue was removed using a hybrid
watershed/surface deformation procedure, subcorti-
cal structures were segmented, and further intensity
normalization was conducted. This was followed
by white-matter segmentation, tessellation of the
gray-white matter boundary, and automated topol-
ogy correction. Finally, surface deformation following
intensity gradients optimally placed the gray/white and
gray/cerebrospinal fluid borders at the location where
the greatest shift in intensity defines the transition to the
other tissue class. The cerebral cortex was parcellated
into 34 gyral-based regions in each hemisphere based
on the Desikan-Killiany atlas [33]. Subcortical struc-
tures were delineated by an algorithm that examines
variations in voxel intensities and spatial relationships.
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Anatomical accuracy of the segmentations was manu-
ally verified. To account for differences in head size,
volumes for each region were divided by intracranial
volume (ICV).
Regions of interest
Morphometric analyses were conducted on a sub-
set of regions that were the focus of our hypotheses
(Fig. 1, left panel), namely the FS executive sys-
tem (frontal cortical regions including caudal middle
frontal gyrus, rostral middle frontal gyrus, superior
frontal gyrus, areas of the inferior frontal gyrus includ-
ing pars triangularis, pars opercularis, pars orbitalis,
and striatal regions including caudate, putamen) and
the MTL memory system (temporal pole, entorhinal
cortex, parahippocampus, hippocampus) [16].
Statistical analyses
Z-scores for memory measures were residualized
by calculating the residuals from the regression of
age and gender onto each brain volume for each
group separately. Since levodopa dosage and other
clinical variables (i.e., disease severity, motor symp-
tom severity on the UPDRS Part III) could have
an effect on cognition in PD, correlations were per-
formed between CVLT variables and clinical variables.
The CVLT variables did not significantly correlate
with the UPDRS or disease duration. (p > 0.05). How-
ever, CVLT learning (r = –.33, p = 0.011) and retention
(r = –.31, p = 0.02) significantly correlated with lev-
odopa dosage equivalence, indicating that higher
levodopa dosage equivalences were associated with
poorer learning and retention. Therefore, residuals
from the regression of levodopa equivalencies, age,
Fig. 1. Regional volumes of interest and their association with memory in Parkinson’s patients. 1) Left panel: Colored areas designate regions of
interest (ROI) in the frontostriatal and medial temporal systems. ROIs on sagittal surfaces are displayed for one hemisphere, but were analyzed
for homologous areas of both hemispheres. The caudate/putamen and the hippocampus are respectively shown on axial and coronal views. 2)
Right panel: Right hemisphere cortical (lateral/medial sagittal surfaces) and hippocampus (coronal view) volumes that significantly correlated
with various memory measures. For CVLT learning (top row), the left hemisphere medial surface displays the significant correlation with the
temporal pole. The p value for correlation coefficients is designated by the color bar; p≤ 0.01 (dark blue) and p≤ 0.005 (light blue).
976 E. Pirogovsky-Turk et al. / Structural MRI and Memory in Parkinson’s
and gender onto CVLT learning and CVLT retention
were calculated for each group separately. For all other
CVLT variables, residuals from the regression of age
and gender onto these CVLT variables were calculated
for each group separately. For most variables, Pearson
correlations were conducted between the residuals
for the CVLT variables and regional volumes, sepa-
rately for each group. Spearman rank correlations were
conducted for cued recall intrusions and recognition
memory hits and false positives due to skewed distri-
butions of measures. Owing to our a priori hypotheses,
which were driven by previous results [16], a more
stringent uncorrected statistical threshold of p≤ 0.01
was adopted in lieu of overly conservative adjust-
ments [34]. This threshold was chosen in an attempt to
strike a balance between Type I and Type II errors.




T tests and Mann-Whitney U tests (cued recall intru-
sions, recognition memory hits and false positives)
compared the groups on the CVLT variables (Table 2).
The PD-woMCI group performed significantly worse
than the HC group on learning (p = 0.008). A repeated-
measure ANOVA showed that patients’ rate of learning
was similar to that of the HC group across all 4 learn-
ing trials (nonsignificant group X trial interaction;
mean (SD) for the slope of the learning function was
0.80 (.43) and 0.78 (.38) for the PD-woMCI and HC
groups, respectively). Thus, verbal learning was poorer
in the PD-woMCI group, irrespective of the learning
trial. In patients, learning was not correlated (p > 0.20)
with measures of executive functioning, attention,
or visuospatial functioning (Table 1). Partial correla-
tions, adjusting for levodopa dosage equivalence, also
showed no significant associations between learning
and measures of executive functioning, attention, or
visuospatial functioning. Group differences were not
found on any other memory measures. Importantly,
the range of values was more restricted for retention,
cued retrieval, cued recall intrusions, and recognition
retrieval relative to all other measures. Additionally,
a cued retrieval-deficit profile (z-score >1.5 difference
between cued recall d prime and long delay free recall)
was found in only 8% (n = 4) of PD-woMCI and 2%
(n = 1) controls. A recognition retrieval-deficit profile
(z-score >1.5 difference between recognition memory
d prime and long delay free recall) was found in 14.5%
(n = 7) of PD-woMCI and 5% (n = 2) of controls.
Group differences in regional volumes
Group comparisons (t-tests) showed right putamen
volume loss (HC: M = 0.35, SD = 0.05; PD-woMCI:
M = 0.33, SD = 0.04; p = 0.005) and a nonsignificant
trend for left putamen volume loss (HC: M = 0.36,
SD = 0.06; PD-woMCI: M = 0.34, SD = 0.04; p = 0.02)
in the PD-woMCI group. No other group differences
were found in MTL/FS volumes.
Correlation of regional volumes with different
components of memory
Figure 1 (right panel) and Table 3 display the
regional maps and significant correlation coefficients
between brain volumes and performances on CVLT
Table 3
Significant correlations between regional frontostriatal and medial temporal lobe volumes and episodic verbal memory performance in the
Parkinson’s group
Regions Learning Long Delay Long Delay Recognition Recognition
Free Recall Cued Memory Memory
Recall Hits False Positives
Frontostriatal System
R Pars triangularis 0.33a 0.35a
Medial Temporal System
R Entorhinal 0.39a
R Parahippocampus 0.44b 0.34a 0.33a 0.33a
R Hippocampus 0.37b 0.39b –0.40b
L Temporal Pole 0.36a
Only memory indices that exhibited significant correlations with brain volumes are displayed. Pearson correlation coefficients are reported,
except for recognition memory hits and false positives, which are Spearman correlation coefficients. R = right hemisphere; L = left hemisphere.
ap≤ 0.01; bp≤ 0.005.
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Fig. 2. Scatter plots showing significant correlations between measures of memory and regional volumes in Parkinson’s patients. For most
variables, age and gender adjusted residuals for MRI volumes and CVLT measures are plotted. An exception is CVLT learning, for which
levodopa dosage equivalence, age, and gender adjusted residuals are plotted. Solid and dotted lines display the best-fitting linear regression line
and 95% confidence intervals.
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variables for the PD-woMCI group. Figure 2 shows
scatter plots of the significant correlations (age and
gender adjusted residuals). In the PD-woMCI group,
worse learning (trials 1 to 4) correlated with smaller
right entorhinal, right parahippocampus, right hip-
pocampus, and left temporal pole volumes. Poorer
long delayed free recall correlated with smaller right
parahippocampus volume. Brain volumes did not
correlate with retention or the long delayed cued
retrieval and recognition retrieval indices. As for sub-
measures of cued retrieval, poorer long delayed cued
recall correlated with smaller right pars triangularis,
parahippocampus, and hippocampus volumes. Cued
recall intrusions did not correlate with brain volumes.
As for sub-measures of recognition retrieval, greater
hits correlated with larger right pars triangularis and
hippocampus volumes, whereas more false positives
correlated with smaller right hippocampus volumes.
No significant correlations were found in the HC group.
Brain volumes for regions that significantly corre-
lated with various memory variables are displayed in
Table 1.
DISCUSSION
Our results principally linked subtle changes in
different components of memory functioning in PD-
woMCI with volumes of the MTL. This was found
even for measures expected to emphasize FS function-
ing, namely learning and recognition memory false
positives. Our results are compatible with emerging
studies that reveal interactions between dopamine neu-
rotransmission and hippocampal synaptic plasticity in
memory [35]. Memory impairments that predate or
predict dementia are also associated with a loss of
cholinergic function and the accumulation of Lewy
Bodies, amyloid plaques, and neurofibrillary tangles
[36, 37]. In contrast, we found that FS volumes were
only associated with sub-measures of the cued retrieval
and recognition indices, namely long delayed cued
recall and recognition memory hits, which correlated
with smaller volumes of the right pars triangularis, an
element of the right-hemisphere ventral-attention sys-
tem [38]. This is fitting as the ventral prefrontal cortex
modulates reorienting responses to task-relevant stim-
uli [38–40], which is elicited by cued memory testing
formats. These neurocognitive relationships were not
found in controls, suggesting that they are related to
subtle changes in the disease, rather than normal aging.
Episodic memory in PD-woMCI was significantly
worse than controls only for learning, which was not
correlated with executive functioning, as it is in cog-
nitively impaired PD [18], nor FS volumes. These
findings suggest that poorer learning was not related
to executive aspects of encoding, but rather dimin-
ished encoding functions of the MTL. Indeed, poorer
learning correlated with smaller right-hemisphere hip-
pocampus, parahippocampus, and entorhinal cortex
volumes and left-hemisphere temporal pole volume,
unlike other studies [7]. This result is consistent with
right-hemisphere MTL mediation of verbal learn-
ing and integration of contextual information (e.g.,
recency, novelty, familiarity) for encoding and retrieval
[41–43]. Long delayed free recall was also associated
with smaller right parahippocampal volume. The find-
ing that verbal learning and memory were associated
with mostly right hemisphere, medial temporal lobe
volumes was somewhat surprising, but is consistent
with a study reporting an association between right,
but not left hippocampal volumes and verbal learning
in PD patients without dementia [7]. Future studies in
larger samples of PD-woMCI should be conducted to
further examine this intriguing finding. Previously we
reported associations between long delay free recall
and bilateral MTL (right and left hippocampus and
entorhinal cortex; left temporal pole) and bilateral FS
(right and left pars triangularis and pars orbitalis, left
superior frontal, right putamen) volumes in nonde-
mented PD [16]. More pervasive bilateral hemispheric
associations may have been driven by the inclusion of
PD-MCI patients, which underscores the importance
of characterizing MCI status when studying neurocog-
nitive relationships.
As for other primary memory indices, recogni-
tion retrieval, cued retrieval, and retention were also
not impaired in PD-woMCI, nor did they correlate
with MTL or FS volumes. These findings may relate
to the small proportion of PD-woMCI patients who
exhibited a cued retrieval-deficit (14.5%) or recogni-
tion retrieval-deficit (8%) profile. Indeed, the retrieval
hypothesis has been questioned more recently, since
the magnitude of impairment in delayed recall and
recognition memory is similar in most nondemented
PD patients [22–24], as we found in PD-woMCI. In
prior studies, the absence of a benefit in recogni-
tion memory testing relative to free recall was due to
increased false positives on recognition testing [23],
presumably owing to FS-based disinhibition. How-
ever, recognition memory false positives and cued
recall intrusions were not elevated in our PD-woMCI
group, nor were these measures related to FS vol-
umes. Altogether, retrieval impairments in PD-woMCI
were uncommon, which likely rendered correlations
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between retrieval indices and regional volumes insen-
sitive.
Limitations of our study include the high educa-
tional levels of many participants, which may limit
the generalizability of the results. Although a more
stringent uncorrected statistical threshold of p≤ 0.01
was adopted in lieu of overly conservative adjustments,
future studies are needed to validate our findings. Addi-
tionally, our level 1 criteria for MCI did not include
a language assessment, however language is usually
intact in PD patients without deficits in other cognitive
domains [28]. Level 1 criteria also provide less diag-
nostic certainty than level 2 criteria [6, 31]. Thus, larger
studies with comprehensive level 2 PD-MCI diagno-
sis should be used in future studies to substantiate
these findings. Although learning did not correlate with
our measures of executive, attention, and visuospatial
functioning, it is possible that other aspects of func-
tioning in these domains not measured in this study
(e.g., problem solving, cognitive flexibility, visuocon-
struction) could be associated with poorer learning in
PD-woMCI. Another caveat is that functional changes
in the FS system may be more broadly associated
with changes in different facets of memory in PD-
woMCI than suggested by our results and possibly
precede macrostructural changes in grey matter [44].
Indeed, though 18-month increases in gray-matter thin-
ning of the caudal middle-frontal cortex in PD-woMCI
patients was recently found, cortical thinning was not
associated with performances on global dementia rat-
ing scales [45]. Microstructural changes in FS fiber
pathways could also affect executive functions that
support various components of memory [46], as well
as changes in other pathological processes that alter
dopaminergic and non-dopaminergic neurotransmitter
systems [47]. Nonetheless, structural MRI will remain
an important marker of cognitive decline as it is sen-
sitive to changes in cognition and has advantages over
other imaging methods, including its reliability and
validation for use in clinical settings.
In summary, subtle changes in several different
facets of memory in PD-woMCI were predominantly
associated with MTL volumes, whereas cued retrieval
and recognition memory were associated with FS vol-
umes. This was found despite an absence of MTL and
frontal cortex atrophy. Our results build upon emerging
evidence linking structural changes in the MTL with
memory function in PD-woMCI [7] and risk for future
cognitive decline [12]. Longitudinal studies underway
will directly determine if these associations are mark-
ers of future memory decline, which if substantiated
may help establish cut-off values (e.g., smaller MTL
and FS volumes combined with poorer memory) that
signify a greater risk for memory impairment.
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